H3N2 Influenza-A Virus New York/55/04 Recombinant ( H3N2 New-York )

Catalog # PT_41611

Print

$201.00
DescriptionRecombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 70,000 dalton.SourceBaculovirus Insect Cells.Physical AppearanceSterile Filtered colorless
Product Size: 2ug
Quantity

Data sheet

Formulation
The Recombinant H3N2 A/New-York/55/04 solution contains 10mM Sodium phosphate, pH 7.2 and 150mM NaCl.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Description
Recombinant Full-Length H3N2 A/New York/55/04 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is 70,000 dalton.
Protein Background
H3N2 is a subtype of the influenza A virus. Its name derives from the forms of the two kinds of proteinson the surface of its coat, hemagglutinin(H) and neuraminidase(N). H3N2 exchanges genes for internal proteins with other influenza subtypes. H3N2 has t
Expression host
Baculovirus Insect Cells.
Reagent Appearance
Sterile Filtered colorless solution.
Stability
H3N2 A/New-York/55/04 Recombinant should be stored at 4°C. Do NOT Freeze!
Product Description
Reacts strongly with human HIV positive serum.
New